Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia

NCT07270575 is registered in ClinicalTrials.gov with Cardiovascular and Interventional Radiological Society of Europe as lead sponsor.

NCT NCT07270575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07270575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia
Lead sponsor
Cardiovascular and Interventional Radiological Society of Europe
Phase
Observational
Overall status
Recruiting
Start date
August 31, 2026
Completion date
December 31, 2032
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic limb threatening ischemia, chronic limb-threatening ischemia